Progress and potential: Training in genomic pathology

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 4, 2014, Pages 498-504

  Haspel, Richard L ^a   Olsen, Randall J ^b   Berry, Anna ^c   Hill, Charles E ^d   Pfeifer, John D ^e   Schrijver, Iris ^f   Kaul, Karen L ^g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CURRICULUM; EDUCATION; GENETICS; GENOMICS; GERMLINE MUTATION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; MICROBIOLOGICAL EXAMINATION; NEEDS ASSESSMENT; NEOPLASM; PATHOLOGY; UNITED STATES;

CURRICULUM; GENOME, HUMAN; GENOMICS; GERM-LINE MUTATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICROBIOLOGICAL TECHNIQUES; NEEDS ASSESSMENT; NEOPLASMS; PATHOLOGY; UNITED STATES;

EID: 84898405548     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0359-SA     Document Type: Article

References (64)

1. Roychowdhury S, Iyer MK, Robinson DR, et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med. 2011;3(111):111ra121.
2. Dabbs DJ, Klein ME, Mohsin SK, Tubbs RR, Shuai Y, Bhargava R. High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the Oncotype DX test: an independent quality assurance study. J Clin Oncol. 2011;29(32):4279-4285.
3. Azim HA Jr, Michiels S, Zagouri F, et al. Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement. Ann Oncol. 2013;24(3):647-654.
4. Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367(8): 705-715.
5. Nardi V, Sadow PM, Juric D, et al. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment. Clin Cancer Res. 2013;19(2):480-490.
6. Jones SJM, Laskin J, Li YY, et al. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol. 2010;11(8): R82.
7. Welch JS, Westervelt P, Ding L, et al. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA. 2011;305(15):1577-1584.
8. Heinzen EL, Swoboda KJ, Hitomi Y, et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet. 2012;44(9):1030-1034.
9. Worthey EA, Mayer AN, Syverson GD, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011;13(3):255-262.
10. National Center for Biotechnology Information. GTR: Genetic Testing Registry. http://www.ncbi.nlm.nih.gov/gtr/tests/termpanel. Accessed June 8, 2013.
11. Mayo Medical Laboratories. Hereditary colon cancer multi-gene panel. http://www.mayomedicallaboratories.com/test-catalog/ClinicalandInterpretive/ 61703. Accessed June 8, 2013.
12. Counsyl Web site. https://www.counsyl.com. Accessed June 8, 2013.
13. Sequenom Web site. ht tp://www.sequenomcmm.com/Home/Health-Care- Professionals/Trisomy-21. Accessed June 8, 2013.
14. Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175-2184.
15. Reddy UM, Page GP, Saade GR, et al. Karyotype versus microarray testing for genetic abnormalities after stillbirth. N Engl J Med. 2012;367(23):2185- 2193.
16. Denomme GA, Johnson ST, Pietz BC. Mass-scale red cell genotyping of blood donors. Transfus Apher Sci. 2011;44(1):93-99.
17. Harper AR, Topol EJ. Pharmacogenomics in clinical practice and drug development. Nat Biotechnol. 2012;30(11):1117-1124.
18. Fleischmann RD, Adams MD, White O, et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995; 269(5223):496-512.
19. Long, SW, Williams D, Valson C, et al. A genomic day in the life of a clinical microbiology laboratory. J Clin Microbiol. 2013;51(4):1272-1277.
20. Snitkin ES, Zelazny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4(148):148ra116.
21. Wright AM., Beres SB, Consamus SW, et al. Rapidly progressive, fatal, inhalation anthrax-like infection in a human: case report, pathogen genome sequencing, pathology, and coordinated response. Arch Pathol Lab Med. 2011; 135(11):1447-1459.
22. Zhou, X, Ren L, Meng, Q, et al. Review: the next-generation sequencing technology and application. Protein Cell. 2010;1(6):520-536.
23. Mardis ER. Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet. 2008;9:387-402.
24. Niedringhaus TP, Milanova D, Kerby MB, Snyder MP, Barron AE. Landscape of next-generation sequencing technologies. Anal Chem. 2011; 83(12):4327-4341.
25. Gnirke A, Melnikov A, Maguire J, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol. 2009;27(2):182-189.
26. Duncavage EJ, Magrini V, Becker N, et al. Hybrid capture coupled with next generation sequencing identifies MCPyV integration sites in FFPE preserved tissues. J Mol Diagn. 2011;13(3):325-333.
27. Loman NJ, Misra RV, Dallman TJ, et al. Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol. 2012;5(6):434- 439.
28. Walcoff SD, Pfeifer JD. Modernizing US regulatory and reimbursement policy to support continued innovation in genomic pathology. Personalized Med. 2012;9(3):295-308.
29. Gargis AS, Kalman L, Berry MW, et al. Assuring the quality of nextgeneration sequencing in clinical laboratory practice. Nat Biotechnol. 2012; 30(11):1033-1036.
30. ARUP Laboratories. 2011. Value of genetic counselors in the laboratory. http://www.aruplab.com/files/resources/genetics/White-paper-1-value-of-GCs- inlab.pdf Accessed June 8, 2013.
31. Lusky K. Pulling back the reins on superfluous testing. CAP Today. http://www.cap.org/apps/cap.portal-nfpbtrue&cntvwrPtlt-actionOverride% 2Fportlets%2FcontentViewer%2Fshow&-windowLabelcntvwrPtlt&cntvwrPtlt% 7BactionForm.contentReference%7Dcap-today%2F0910%2F0910b-pulling- back.html&-statemaximized&-pageLabelcntvwr. Published September 2010. Accessed June 8, 2013.
32. Klitzman R, Chung W, Marder K, et al. Attitudes and practices among internists concerning genetic testing. J Genet Couns. 2013;22(1):90-100.
33. Guttmacher AE, Porteous ME, McInerney JD. Educating health-care professionals about genetics and genomics. Nat Rev Genet. 2007;8(2):151-157.
34. Salari K. The dawning era of personalized medicine exposes a gap in medical education. PLoS Med. 2009;6(8):e1000138.
35. Nelson EA, McGuire AL. The need for medical education reform: genomics and the changing nature of health information. Genome Med. 2010;2(3):18.
36. Feero WG, Green ED. Genomics education for health care professionals in the 21st century. JAMA. 2011;306(9):989-990.
37. Thurston VC, Wales PS, Bell MA, Torbeck LJ, Brokaw JJ. The current status of medical genetics instruction in U.S. and Canadian medical schools. Acad Med. 2007;82(5):441-445.
38. Telner D, Carroll JC, Talbot Y. Genetics education in medical school: a qualitative study exploring educational experiences and needs. Med Teach. 2008;30(2):192-198.
39. Salari K, Pizzo PA, Prober CG. Commentary: to genotype or not to genotype: addressing the debate through the development of a genomics and personalized medicine curriculum. Acad Med. 2011;86(8):925-927.
40. Dhar SU, Alford RL, Nelson EA, Potock L. Enhancing exposure to genetics and genomics through an innovative medical school curriculum. Genet Med. 2012;14(1):163-167.
41. Walt DR, Kuhlik A, Epstein SK, et al. Lessons learned from the introduction of personalized genotyping into a medical school curriculum. Genet Med. 2011; 13(1):63-66.
42. Wiener CM, Thomas PA, Goodspeed E, Valle D, Nichols DG. ''Genes to society'': the logic and process of the new curriculum for the Johns Hopkins University School of Medicine. Acad Med. 2010;85(3):498-506.
43. Patay BA, Topol EJ. The unmet need of education in genomic medicine. Am J Med. 2012;125(1):5-6.
44. Intersociety Council for Pathology Information. Career opportunities in pathology. http://www.pathologytraining.org/trainees/documents/recruit.ppt. Published June 2013. Accessed June 8, 2013.
45. Tonellato PJ, Crawford JM, Boguski MS, Saffitz JE. A national agenda for the future of pathology in personalized medicine: report of the proceedings of a meeting at the Banbury Conference Center on genome-era pathology, precision diagnostics, and preemptive care: a stakeholder summit. Am J Clin Pathol. 2011; 135(5):668-672.
46. Ross JS. Next-generation pathology. Am J Clin Pathol. 2011;135(5):663- 665.
47. Haspel RL, Atkinson JB, Barr FG, et al. TRIG on track: educating pathology residents in genomic medicine. Personalized Med. 2012;9(3):287-293.
48. Haspel RL, Arnaout R, Briere L, et al. A curriculum in genomics and personalized medicine for pathology residents [online supplement]. Am J Clin Pathol. 2010;133(6). http://ajcp.ascpjournals.org/site/misc/pdf/Haspel-online. pdf. Accessed June 8, 2013.
49. Haspel RL, Arnaout R, Briere L, et al. A call to action: training pathology residents in genomics and personalized medicine. Am J Clin Pathol. 2010;133(6): 832-834.
50. Kern DE, Thomas, PA, Howard DM, Bass EB. Curriculum Development for Medical Education: A Six Step Approach. Baltimore, MD: The Johns Hopkins University Press; 1998.
51. Elliott R, Jacobs WC. Multiple sclerosis. http:// genomicmedicineinitiative.org/wp-content/uploads/2010/03/Multiple-Sclerosis.pdf. Published 2010. Accessed June 8, 2013.
52. Callier SL. Swabbing students: should universities be allowed to facilitate educational DNA testing Am J Bioeth. 2012;12(4):32-40.
53. Knowles MS, Holton EF III, Swanson RA. The Adult Learner. 6th ed. Burlington, MA: Elsevier; 2005.
54. Grenzen JR, Krasowski MD. Resident training in clinical chemistry. Clin Lab Med. 2007;27(2):343-358.
55. BIDMC Department of Pathology. 2010. Genomic medicine initiative. genomicmedicineinitiative.org. Accessed June 8, 2013.
56. Schrijver I, Natkunam Y, Galli S, et al. Integration of genomic medicine into pathology residency training: the Stanford Open Curriculum. J Mol Diagn. 2013;15(2)141-148.
57. Stanford University Pathology Faculty. 2012. Stanford open curriculum in genomic medicine. http://www.youtube.com/playlistlist PLfTljtR5bxMcTg8hgQp9sA4YQwicpSAQv. Accessed June 8, 2013.
58. The Training Residents in Genomics (TRIG) Working Group 2012. Lecture materials. http://www.pathologytraining.org/trig-lecture.htm. Accessed June 8, 2013.
59. The Training Residents in Genomics (TRIG) Working Group 2013. TRIG Web site. http://ascp.org/TRIG. Accessed June 8, 2013.
60. Haspel RL. How can we teach genomic medicine to pathology professionals Crit Values. 2013;6(1):19.
61. Haspel RL. NCHPEG Member news: free genomic medicine PowerPoint lectures now available. 2012. National Coalition for Health Professional Education in Genetics. http://www.nchpeg.org/index.phpoption com- content&viewarticle&id400:nchpeg-member-news-free-genomicmedicine- powerpoint-lectures-now-available-from-the-intersociety-council-forpathology- information-&catid92:in-practice-fall-2012&Itemid271. Accessed June 8, 2013.
62. Rinder HM, Grimes MM, Wagner J, et al. Senior pathology resident inservice examination (RISE) scores correlate with outcomes of the American Board of Pathology (ABP) certifying examinations. Am J Clin Pathol. 2011;136(4):499- 506.
63. The Association for Molecular Pathology Training and Education Committee. Goals and objectives for molecular pathology education in residency programs. J Mol Diagn. 1999;1(1):5-15.
64. Talbert ML, Dunn ST, Hunt J, et al. Competency-based education for the molecular genetic pathology fellow: a report of the association for molecular pathology training and education committee. J Mol Diagn. 2009;11(6):497-507.